Prescribing generics: All in a name

[...]only 157 such stores could be opened by December 2012, and the number was reduced to 99 subsequently. [...]these stores were providing only 130 of the 319 selected medicines, and only 50 per cent of these medicines were physically available for dispensing[5]. Before April 2017, companies manufacturing generic versions of medicines did not have to prove their bioequivalence to their branded/innovator congeners. [...]thousands of both branded and non-branded medicines are available in the Indian market, which have not been tested for bioequivalence. [...]in case of biologicals, the term generic is not used. [...]the drug regulator's office, the Central Drug Standard Control Organization (CDSCO) should list all the medicines available in the Indian market along with their available generic versions and costs on a public portal, accessible to everyone.